Radiopharmaceuticals Market Growth, Future Prospects And Competitive Analysis To 2032

 The global radiopharmaceuticals market stands at US$ 6.2 Bn as of now and is expected to reach US$ 9.5 Bn by the year 2032 at a CAGR of 4.3% between 2022 and 2032.

Radiopharmaceuticals imply medications containing radioisotopes that could be used as both – therapeutic agents and diagnosis medications. Radiopharmaceuticals manage critical as well as chronic diseases. These days, various diagnostics are aimed towards organs with nuclear medicine radiopharmaceuticals.

PET and SPECT techniques are used in abundance while deploying radiopharmaceuticals. Some of the distinct features of radiopharmaceuticals include non-invasiveness, cost-effectiveness, easy of diagnosis, and higher sensitivity. Clinical applications include cardiology, oncology, lymphoma, and tumor.

Growing awareness regarding positive results provided by radiopharmaceuticals in checking chronic illness is one of the catalysts to radiopharmaceuticals market.

On the other hand, the fact that radiopharmaceuticals have half-life could restrain the market. It’s a known fact that radiopharmaceuticals involve higher investment. Short expectancy or half-life is one of the crucial factors restricting demand for radiopharmaceuticals. Thus, it’s only the developed regions who are able to increasingly adopt radiopharmaceuticals as of now. The developing economies still need to incorporate the technology to the fullest. Future Market Insights has walked through these functionalities with future prospects in its latest market study entitled ‘Radiopharmaceuticals Market’.

Key Takeaways from Radiopharmaceuticals Market

  • North America dominates the radiopharmaceuticals market due to rising frequency of cardiovascular diseases and cancer and the scenario is expected to persist even in the forecast period. Adopting innovative radioisotope production methods for treating chronic disorders is another reason.
  • Europe, led by the UK, is also expected to hold a significant market share due to the UK being subject to maximum incidences of cancer. Cancer Research UK estimate says that the UK alone houses 367,167 cancer patients.
  • The Asia-Pacific is poised to grow blatantly in the forecast period with it witnessing new product launches, collaborations, distribution agreements, acquisitions in an aplomb.

“The fact that radiopharmaceuticals are broadly used as biomarkers in molecular imaging is expected to take the radiopharmaceuticals market by storm in the upcoming period”, says an analyst from Future Market Insights.

Competitive Landscape

  • GE Healthcare inked an agreement with NorthStar Medical Radioisotopes, LLC for producing and distributing iodine-123 (I-123) capsules all across the US.
  • Bracco Diagnostics Inc., in March 2021, entered into partnership with CardioNavix, LLC for enhancing patients’ access to cardiac PET imaging. The new program is termed as ‘Bracco Mobile Isotope Service’, which ought to facilitate better patient care sites for providing cardiac PET imaging.
  • Jubilant Radiopharma, in August 2020, signed a MoU (Memorandum of Understanding) with Navidea Biopharmaceuticals, which focuses on an ELDA (Exclusive License and Distribution Agreement) for the latter’s diagnostic imaging agent called ‘Tilmanocept (technetium Tc 99m tilmanocept injection) in LATAM, Mexico, Canada, and the US.
  • Bayer AG, in June 2021, announced that it would acquire Noria Therapeutics Inc. along with PSMA Therapeutics Inc. with the objective of widening the former’s oncology portfolio that is into existence.
  • Norgine B.V., in March 2020, completed the acquisition of Azanta A/S, a specialty biopharmaceutical company. This included Nimorazole, a hypoxic radiosensitizer to treat cancer, and Angusta to facilitate labor induction.
  • Curium, in the year 2019, completed acquisition of MAP Medical, which would actually help it in strengthening the footprint all over the Europe with access to Baltic and Nordic countries.
  • The US FDA, in December 2020, completed approval of Gallium 68 PSMA-11 (Ga 68 PSMA-11). It holds the distinction of being the very first drug for PET imaging for diagnosing prostate cancer.

Top Radiopharmaceuticals companies : Siemens AG,Positron Corporation,Novartis (Advanced Accelerator Applications),Curium,GE Healthcare,Lantheus Holdings Inc.,Sotera Health LLC (Nordion Inc.),Bayer AG,Eckert & Ziegler,

Key Segments Covered in the Radiopharmaceuticals Industry Analysis

Radiopharmaceuticals Market by Radioisotope Type:

  • Technetium-99
  • Fluorine-18
  • Iodine-131
  • Leutetium-177
  • Yttrium-90
  • Gallium-68
  • Gallium-67
  • Rubidium-82
  • Iodine-123
  • Iodine-125
  • Indium-111
  • Others

Radiopharmaceuticals Market by Application:

  • Oncology
  • Cardiology
  • Gastroenterology
  • Neuroendocrinology
  • Neurology
  • Nephrology
  • Others

Radiopharmaceuticals Market by Source:

  • Cyclotrons
  • Nuclear Reactors

Radiopharmaceuticals Market by End User:

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Cancer Research Institute

Comments

Post a Comment

Popular posts from this blog

Laboratory Information Systems (LIS) Market Segmentation Application, Technology & Analysis Research Report To 2032

  Global  laboratory information system (LIS) market size   revenues are set to grow at 10.2% CAGR through 2030, according to an updated edition by Future Market Insights (FMI). The 2022-2030 version of the report builds upon the widely cited previous version, and incorporates the latest developments, notably, the impact of COVID-19 pandemic on this market. Massive technical improvements in the healthcare sector over time have included automation, big data analytics, and cloud computing. The necessity to balance administrative and caring activities is the most crucial factor in the sector. Thanks to the development of sophisticated laboratory testing technologies, this is now achievable. The cornerstone of managing primary healthcare is laboratories. Drug development and the creation of APIs take place in laboratories. It is necessary to streamline repetitive tasks like data collection, assimilation, and record maintenance in order to increase the speed at which these processes are eff
Read more

Automotive AC Compressor Market : Industry Future Set To Massive Growth With High CAGR Value By 2032

  The sales of   automotive ac compressor market share   is estimated to grow at an average CAGR of 3.9% over the forecast period. The automotive AC compressor market size is projected to reach US$ 9,342.1 Mn in 2022, and is estimated to reach US$ 13,696.2 Mn in 2032. Growing economic values in emerging countries, as well as rising purchasing power, are predicted to boost the rise of car ownership, hence driving the automotive AC compressor market share. However, high startup and instalment costs, as well as maintenance concerns, are anticipated to limit the sales of vehicle AC compressors. On the other hand, technological advancements and the introduction of new products are projected to drive the growth of the automotive AC compressor market size. The increasing use of air conditioning in passenger vehicles in developing countries are likely to drive demand for automotive AC compressors during the forecast period. Furthermore, as environmental regulations tighten, vehicle makers are
Read more

Urgent Care Market Future Scenario, Key Insights, Top Companies 2032

  Between 2022 and 2032, the   urgent care market demand   is anticipated to increase globally at a moderate CAGR of roughly 5.4%, resulting in sizable revenues by the end of the projection period (2032). Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Urgent Care Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as along with the key takeaways over the forecast.   The team of analysts at Future Market Insights are focussing on research and market study to produce different Urgent Care Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Urgent Care Market. Key Players The writer will create content on the general strategies o
Read more